Iranian Red Crescent Medical Journal

Published by: Kowsar

AXIN2 is Associated With Papillary Thyroid Carcinoma

Xin Liu 1 , Shuang Li 1 , Xuejun Lin 1 , Kangkang Yan 1 , Longyu Zhao 1 , Qiong Yu 1 , * and Xiaodong Liu 2 , 3 , *
Authors Information
1 Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, China
2 Department of Radiology and Radiation Oncology, China-Japan Union Hospital, Changchun, China
3 Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China
Corresponding Authors:
Article information
  • Iranian Red Crescent Medical Journal: February 01, 2016, 18 (2); e20960
  • Published Online: January 1, 2016
  • Article Type: Rapid Communication
  • Received: June 4, 2014
  • Revised: January 20, 2015
  • Accepted: March 14, 2015
  • DOI: 10.5812/ircmj.20960

To Cite: Liu X, Li S, Lin X, Yan K, Zhao L, et al. AXIN2 is Associated With Papillary Thyroid Carcinoma, Iran Red Crescent Med J. 2016 ; 18(2):e20960. doi: 10.5812/ircmj.20960.

Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Leenhardt L, Grosclaude P, Cherie-Challine L, Thyroid Cancer C. Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid. 2004; 14(12): 1056-60[DOI][PubMed]
  • 2. Vriens MR, Suh I, Moses W, Kebebew E. Clinical features and genetic predisposition to hereditary nonmedullary thyroid cancer. Thyroid. 2009; 19(12): 1343-9[DOI][PubMed]
  • 3. Wang Z, Zhang H, He L, Dong W, Li J, Shan Z, et al. Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma. Onco Targets Ther. 2013; 6: 281-7[DOI][PubMed]
  • 4. Liu X, He M, Hou Y, Liang B, Zhao L, Ma S, et al. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma. Oncol Rep. 2013; 29(4): 1415-20[DOI][PubMed]
  • 5. Ikeda S, Kishida M, Matsuura Y, Usui H, Kikuchi A. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin. Oncogene. 2000; 19(4): 537-45[DOI][PubMed]
  • 6. Schmid S, Bieber M, Zhang F, Zhang M, He B, Jablons D, et al. Wnt and hedgehog gene pathway expression in serous ovarian cancer. Int J Gynecol Cancer. 2011; 21(6): 975-80[DOI][PubMed]
  • 7. Mai M, Qian C, Yokomizo A, Smith DI, Liu W. Cloning of the human homolog of conductin (AXIN2), a gene mapping to chromosome 17q23-q24. Genomics. 1999; 55(3): 341-4[DOI][PubMed]
  • 8. Yamamoto H, Kishida S, Uochi T, Ikeda S, Koyama S, Asashima M, et al. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos. Mol Cell Biol. 1998; 18(5): 2867-75[PubMed]
  • 9. Pinarbasi E, Gunes EG, Pinarbasi H, Donmez G, Silig Y. AXIN2 polymorphism and its association with prostate cancer in a Turkish population. Med Oncol. 2011; 28(4): 1373-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments